Kreon (Pancreatin)

Pancreatin in Kreon provides the three major digestive enzymes—lipase, amylase and protease. When taken with meals, these enzymes act in the small intestine to hydrolyze triglycerides, starches and proteins, respectively, compensating for the patient’s deficient pancreatic secretion and facilitating nutrient absorption.

The appropriate dose of Kreon is individualized and set by the prescribing healthcare professional. Dosage is typically adjusted according to the patient’s weight, severity of enzyme deficiency, dietary fat content and clinical response, with regular monitoring to achieve optimal nutritional outcomes.

Safety data for Kreon in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. Healthcare providers should evaluate the potential benefits against any possible risks before prescribing it to pregnant or nursing individuals.

To request Kreon, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Kreon contains a standardized blend of lipase, amylase and protease similar to other pancreatic enzyme brands such as Creon or Pancrease. Differences may lie in enzyme potency per capsule, formulation excipients, and regulatory approvals. Clinicians choose a product based on patient tolerance, dosing convenience and local availability.

Kreon should be stored at ambient temperature, below 25 °C, in its original container to protect it from moisture and excessive heat. Keep the capsules tightly sealed and out of reach of children. Do not store in humid environments such as bathrooms.

Kreon is taken orally, usually with each main meal and snack that contains fat. The capsules should be swallowed whole with water; they are not intended to be opened, crushed or mixed with food unless specifically instructed by a healthcare professional.

Serious adverse events, although rare, include severe allergic reactions (anaphylaxis, rash, swelling), acute pancreatitis exacerbation, intestinal obstruction and persistent severe abdominal pain. Patients should seek immediate medical attention if they experience any of these symptoms.

Kreon is contraindicated in individuals with a known hypersensitivity to porcine-derived proteins or any component of the formulation. Patients with severe, uncontrolled gastrointestinal disorders or those who have experienced a serious allergic reaction to pancreatic enzyme products should avoid its use.